查詢結果分析
相關文獻
- Expression of Glucose Transporter-1 in Taiwanese Patients with Breast Carcinoma--A Preliminary Report
- HER2免疫組織化學染色之檢體製備
- HER2檢測品質的臨床重要性
- The Effects of Pesticides Chlordane, Dieldrin and Endosulfan on the Growth of Human Breast Cancer Cell Lines MCF-7 and SK-BR-3
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Cystic Hypersecretory Intraductal Carcinoma of the Breast--Case Report
- Timing of Shoulder Exercise after Modified Radical Mastectomy: A Prospective Study
- 前哨淋巴掃描診斷乳癌早期轉移
- Measurement of the Quality of Life during Different Clinical Phases of Breast Cancer
- The Prognostic Significance of Pathologic Characteristics of Breast Cancer Patients in Taiwan
頁籤選單縮合
題 名 | Expression of Glucose Transporter-1 in Taiwanese Patients with Breast Carcinoma--A Preliminary Report=臺灣乳癌患者Glucose Transporter-1基因表現--初步報告 |
---|---|
作 者 | 郭守仁; 吳曜充; 陳君萍; 曾信順; 陳達人; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷 期 | 22:7 民95.07 |
頁 次 | 頁339-345 |
分類號 | 416.226 |
關鍵詞 | 乳癌; 葡萄糖轉運蛋白基因; 免疫組織化學染色法; Breast carcinoma; Glucose transporter-1; Immunohistochemistry; |
語 文 | 英文(English) |
中文摘要 | 在實驗室及活體實驗中顯示,惡性細胞會增加醣類的攝取。Glucose transporter-1 gene (GLUT1) 已經在很多的人類腫瘤細胞被發現。這個實驗的目的主要想探討在台灣的乳癌患者是否與 glucose transporter-1 基因兩者之間有所關聯以及臨床上對於預後有沒有影響 ? 我們收集了 39 個乳癌患者並針對其檢體作分析,發現有 28 個病人 (71.8%) 對 GLUT1 分別有強度不同的表現,其中 1+ 有 19 個病人佔了 48.7%,2+ 有 6 個病人佔了 15.4%,3+ 有 3 個病人佔了 7.7%。最後我們發現在臨床乳癌病人的預後,復發率,以及存活率與 GLUT1 基因並無明顯的相關性。 |
英文摘要 | Malignant cells show increased glucose uptake in vitro and in vivo. High expression of the glucose transporter-1 gene (GLUT1) has been found in many human tumor tissues. The aim of this study was to investigate the correlation between GLUT1 expression in breast carcinomas of Taiwanese patients and clinical prognostic parameters. Twenty-eight (71.8%) of the 39 breast carcinomas analyzed showed positive GLUT1 expression with different intensities: 1+, 19 cases (48.7%); 2+, 6 cases (15.4%), 3+, 3 cases (7.7%). No significant correlation was seen between GLUT1 expression and clinical prognostic parameters such as tumor size (p = 0.085), age (p = 0.4528), axillary lymph node metastasis (p = 0.9562), nuclear grade (p = 0.6895), estrogen receptor-positive (p = 1.0000), and progesterone receptor-positive (p = 0.9689). |
本系統中英文摘要資訊取自各篇刊載內容。